Clinical Trial

Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplinary Molecular Biology Meeting of Eastern PACA

Study acronym: TARGET
Recruiting
View on ClinicalTrials.gov →
Summary
This study will evaluate the diagnostic performance of liquid biopsy for identifying molecular abnormalities among patients managed by the Multidisciplinary Molecular Biology Meeting. The gold standard considered in this study is the solid biopsy.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-09-19; most recent amendment 2026-07-17.
Status change: Not Yet Recruiting → Recruiting 2025-03-03
Trial Details
NCT Number NCT06606366
Lead Sponsor Centre Antoine Lacassagne
Conditions Neoplasm Malignant
Enrollment 238 participants
Start Date 2025-03-03
Primary Completion 2027-06-03 (estimated)
Study Completion 2027-06-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-20